Annals of Clinical and Translational Neurology

Papers
(The H4-Index of Annals of Clinical and Translational Neurology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia130
The case of a 49‐year‐old man with involuntary toe movements95
Issue Information81
The Case of a 25‐Year‐Old Woman With Isolated Head Tremor57
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke53
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome52
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes51
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study50
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels49
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study48
SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights48
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states47
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies46
Association of serum Spp1 levels with disease progression in ALS and SBMA45
Discrepant expressive language lateralization in children and adolescents with epilepsy45
Order from chaos: Using CSF proteomics to predict ALS progression44
Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis43
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D43
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation42
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐42
SARSCoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis42
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration41
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan39
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes39
Dementia Incidence in Individuals With Parkinson's Disease in the Framingham Heart Study37
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients37
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression36
Cognitive impairment in pulmonary arterial hypertension36
Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease36
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA35
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab34
Peripheral nervous system manifestations of MOG antibody associated disease33
Development of a Prediction Model for Progression Risk in High‐Grade Gliomas Based on Habitat Radiomics and Pathomics33
0.087850093841553